Who are InterCure Ltd.'s main suppliers?

InterCure Ltd. (INCR) key suppliers include: GMP-CERTIFIED-MANUFACTURERS-IN-ISRAEL, Canopy Growth Corporation, NewcelX Ltd., SaverOne 2014 Ltd., XTL Biopharmaceuticals Ltd.. View the full supplier network at chainsifter.com/chain/INCR.

Who are InterCure Ltd.'s major customers?

InterCure Ltd. (INCR) key customers include: TILRAY-PORTUGAL-UNIPESSOAL-LTD, Tilray Brands, Inc., Canopy Growth Corporation, Canopy Growth Corporation, XTL Biopharmaceuticals Ltd. and 12 more. View the full customer network at chainsifter.com/chain/INCR.

What sector is InterCure Ltd. in?

InterCure Ltd. (INCR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

InterCure Ltd. Suppliers, Customers & Supply Chain (INCR)

5Suppliers

17Customers

0Debt Items

20Related Chains

Source-Backed Evidence Depth

InterCure Ltd. (INCR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

23Total relationships

1Distinct source URLs

4High confidence

0.699Average confidence

2026-10-29Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

InterCure Ltd. Suppliers

Ticker	Name	Confidence	Evidence
GMP-CERTIFIED-MANUFACTURERS-IN-ISRAEL	GMP-CERTIFIED-MANUFACTURERS-IN-ISRAEL	90%	When new Israeli regulations, which increased manufacturing costs, were adopted in 2016, we made a business decision to outsource the extraction and packaging services of our final product to manufac…
CGC	Canopy Growth Corporation	72%	Reciprocal relationship from CGC graph: Reciprocal relationship from INCR graph: Reciprocal relationship from CGC graph: Reciprocal relationship from INCR graph: Reciprocal relationship from CGC grap…
NCEL	NewcelX Ltd.	72%	Reciprocal relationship from NCEL graph: Reciprocal relationship from INCR graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from INCR graph: Reciprocal relationship from NCEL g…
SVRE	SaverOne 2014 Ltd.	72%	Reciprocal relationship from SVRE graph: Reciprocal relationship from INCR graph: Reciprocal relationship from SVRE graph: Reciprocal relationship from INCR graph: Reciprocal relationship from SVRE g…
XTLB	XTL Biopharmaceuticals Ltd.	72%	Reciprocal relationship from XTLB graph: Reciprocal relationship from INCR graph: Reciprocal relationship from XTLB graph: le assets 14 - 1,729 - Gain from sale of investment in associate - (1,051 ) …

InterCure Ltd. Customers

Ticker	Name	Confidence	Evidence
TILRAY-PORTUGAL-UNIPESSOAL-LTD	TILRAY-PORTUGAL-UNIPESSOAL-LTD	85%	l supply chain facilities. InterCure’s EU-GMP manufacturing sites will import, register, and produce Cookies-branded products, including a future range of next-generation offerings such as live resin…
TLRY	Tilray Brands, Inc.	85%	Reciprocal relationship from TLRY graph: Reciprocal relationship from INCR graph: Reciprocal relationship from TLRY graph: Reciprocal relationship from INCR graph: l supply chain facilities. InterCur…
CGC	Canopy Growth Corporation	72%	luding all major pharmacies across Israel. The newly formed company, that will be held jointly by us and by Altman, focuses on the new Israeli CBD product market, following the Israeli Minister of He…
CGC	Canopy Growth Corporation	72%	Reciprocal relationship from CGC graph: Reciprocal relationship from INCR graph: Reciprocal relationship from CGC graph: Reciprocal relationship from INCR graph: Reciprocal relationship from CGC grap…
XTLB	XTL Biopharmaceuticals Ltd.	72%	luding all major pharmacies across Israel. The newly formed company, that will be held jointly by us and by Altman, focuses on the new Israeli CBD product market, following the Israeli Minister of He…
XTLB	XTL Biopharmaceuticals Ltd.	72%	Reciprocal relationship from XTLB graph: le assets 14 - 1,729 - Gain from sale of investment in associate - (1,051 ) - 561 1,695 - Changes in operating asset and liability items: Decrease (increase) …
AHUZA-PHARMACY-D-Y-LTD	AHUZA-PHARMACY-D-Y-LTD	62%	approval. Clinical trials that study pharmaceutical-grade cannabis for these purposes do not require preclinical studies or Phase 1 trials as a condition for the approval of Phase 2 trials. However, …
AURORA-CANNABIS-INC	AURORA-CANNABIS-INC	62%	luding all major pharmacies across Israel. The newly formed company, that will be held jointly by us and by Altman, focuses on the new Israeli CBD product market, following the Israeli Minister of He…
CARMA-HOLDCO-INC	CARMA-HOLDCO-INC	62%	ce cannabis out of Israel. In December 2020, we completed the first commercial export of our products, which consisted of several dozen kilograms, to the European Union as part of the Tilray Agreemen…
CLUB-PHARM-LTD	CLUB-PHARM-LTD	62%	approval. Clinical trials that study pharmaceutical-grade cannabis for these purposes do not require preclinical studies or Phase 1 trials as a condition for the approval of Phase 2 trials. However, …
DORON-PHARMACY-LTD	DORON-PHARMACY-LTD	62%	approval. Clinical trials that study pharmaceutical-grade cannabis for these purposes do not require preclinical studies or Phase 1 trials as a condition for the approval of Phase 2 trials. However, …
F-O-R-E-BIOTHERAPEUTICS-LTD	F-O-R-E-BIOTHERAPEUTICS-LTD	62%	luding all major pharmacies across Israel. The newly formed company, that will be held jointly by us and by Altman, focuses on the new Israeli CBD product market, following the Israeli Minister of He…
LEON-PHARM-LTD	LEON-PHARM-LTD	62%	approval. Clinical trials that study pharmaceutical-grade cannabis for these purposes do not require preclinical studies or Phase 1 trials as a condition for the approval of Phase 2 trials. However, …
PHARMA-ZONE-LTD	PHARMA-ZONE-LTD	62%	ce cannabis out of Israel. In December 2020, we completed the first commercial export of our products, which consisted of several dozen kilograms, to the European Union as part of the Tilray Agreemen…
PHARMAZONE-PHARMACY-LTD	PHARMAZONE-PHARMACY-LTD	62%	vitch Chairman of the Board and CEO Amos Cohen CFO The accompanying notes are an integral part of the consolidated financial statements. F- 4 Intercure Ltd. Consolidated Statements of Profit or Loss …
PRAETORIAN-GLOBAL-INC	PRAETORIAN-GLOBAL-INC	62%	ce cannabis out of Israel. In December 2020, we completed the first commercial export of our products, which consisted of several dozen kilograms, to the European Union as part of the Tilray Agreemen…
SUPER-PHARM-LTD	SUPER-PHARM-LTD	62%	EVA) (TASE: TEVA), a leading Israeli company in the health services field (the “SLE Agreement”). Pursuant to the SLE Agreement, SLE provides us with logistics, storage, collection and distribution se…

InterCure Ltd. Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for InterCure Ltd..

InterCure Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for InterCure Ltd..

InterCure Ltd. Ownership

Holder	Name	Confidence	Evidence
INCR-OWNER-HEALTHCARE-OF-ONTARIO-PENSION-PL	HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	90%	13F overlay lists HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND as top holder; 15 tracked holders.

InterCure Ltd. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
NCEL	NewcelX Ltd.	100.00	1	['supplier']
XTLB	XTL Biopharmaceuticals Ltd.	100.00	1	['customer', 'supplier']
CGC	Canopy Growth Corporation	100.00	1	['customer', 'supplier']
BWAY	BrainsWay Ltd.	100.00	2
ELDN	Eledon Pharmaceuticals, Inc.	100.00	2
ALAR	Alarum Technologies Ltd.	100.00	2
TLRY	Tilray Brands, Inc.	100.00	1	['customer']
SVRE	SaverOne 2014 Ltd.	100.00	1	['supplier']
BUD	Anheuser-Busch InBev SA/NV	50.00	2
ABT	Abbott Laboratories	50.00	2
PBM	Psyence Biomedical Ltd.	50.00	2
SAM	The Boston Beer Company, Inc.	50.00	2
TAP-A	Molson Coors Beverage Company	50.00	2
CX	CEMEX, S.A.B. de C.V.	50.00	2
TAP	Molson Coors Beverage Company	50.00	2
JSDA	Jones Soda Co.	50.00	2
LIEN	Chicago Atlantic BDC, Inc.	50.00	2
NVSEF	Novartis AG	50.00	2
VWAV	VisionWave Holdings, Inc.	50.00	2
TEVA	Teva Pharmaceutical Industries Limited	50.00	2

InterCure Ltd. Supply Chain